Tag: IDE approval
Cerevasc announces US FDA-approved expansion of normal-pressure hydrocephalus study
Cerevasc has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of...
CereVasc announces US FDA approval for second IDE study of eShunt...
CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...
CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...
CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...
NeuroPace gains IDE approval to launch pivotal study of neuromodulation therapy...
NeuroPace has announced that it has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate the NAUTILUS...
